for humans is exposure of the skin to sunlight (UVB 280-315 nm) resulting in the conversion of 7-dehydrocholesterol to previtamin D3. The recent discovery that the human brain also possesses vitamin D receptors 10, 11 indicates that mood and depressive disorders might be influenced by vitamin D deficiency directly, by acting on brain cells.
Other pathways that may be triggered by UV light to modulate mood and act through skin exposure involve three local systems:
(i) the skin analog of the hypothalamic-pituitary-adrenal (HPA) axis, 12 (ii) the serotoninergic/melatoninergic system, 13 and (iii) the immune system. 14, 15 These pathways are assumed to interplay with systemic mechanisms of body homeostasis.
14 Using eyes as a target, bright light therapy is applied for the treatment of seasonal affective disorders (SAD); it is thought that bright light can help to suppress melatonin production in the pineal gland, thereby attenuating many of the symptoms associated with SAD. 16 However, it remains unclear whether UV light has an additional value in the therapeutic light spectrum, or whether it exercises only a deleterious effect on the eyes.
Bearing in mind the theoretical points mentioned above, this review explores and summarizes the evidence obtained from clinical trials and observational studies on the effect of UV light applied to the skin or as a component of light therapy applied to the eyes on mood, depressive disorders, and well-being.
| ME THODS

| Protocol and registration
This systematic review was designed according to the PRISMA method. 17, 18 The protocol is registered and published in the PROSPERO database (PROSPERO 2017: CRD42017059971).
| Eligibility criteria
A PICO (population, intervention, control, outcome)-based search strategy was conducted on 22 March 2017. Eligible for this review was studies in the general population in which: (i) exposure to UV light or sunlight was used as an intervention, and (ii) the effect on mood, depressive disorders, and well-being was measured as an outcome. Included were clinical trials and observational studies on sunlight, in which exposure to sunlight occurred outdoors and the number of exposure hours was recorded.
| Search strategy
With the assistance of an experienced librarian the following bibliographic databases were searched: PubMed, Embase, Web of Science, Cochrane, Psychinfo, CINAHL, Academic Search Premier and Science Direct. Also, the references of key papers and of the included studies were explored. The search strategy included terms related to UV light, mood, affective disorders, and well-being (for the PubMed search strategy see Appendix A). Although no restriction was made regarding the date of publication, articles had to be in English, Dutch, German or Russian.
| Study selection
Of the identified studies, the titles and abstracts were screened by the first author (BV) and categorized on exclusion criteria. The categories were reviewed by the second author (RvB) by randomly assessing the titles and abstracts in the different categories; differences were discussed until consensus was reached. References from the included studies and from key articles were also assessed.
The full-text articles derived from this process were independently assessed by the first and second author; any differences were discussed until consensus was reached.
| Data extraction
Information extracted from the selected studies included: year of publication, study design, study population (characteristics of chronic disease, if any), setting (community, or hospitalized), intervention and control conditions, outcome measures on mood and results, and information for assessment of risk of bias. The first and second author extracted data from the studies independently from each other; any discrepancies were resolved by discussion.
| Risk of bias
Risk of bias of the individual studies was evaluated on outcome level by the first and second author independently, using Cochrane
Collaboration's tool for assessing risk of bias. 19 Risk of bias assessment comprised evaluation of sequence generation, allocation concealment, blinding of participants and outcome assessors, incomplete outcome data, selective outcome reporting, and other bias. Disagreements were resolved through discussion and consensus, or by consulting the last author (MC).
| Data synthesis and analysis
All outcomes on mood, depressive disorders and well-being reported in the studies were extracted. For each study, characteristics including study size, population, intervention, control group, main outcome measures, and follow-up period were described. Synthesis and analysis were performed in a narrative manner and structured according to the site of action of UV light: skin or eyes.
| RE SULTS
| Study selection
After removing duplicates from the 702 articles yielded by the search, 677 records remained ( Figure 1 ). After screening on title (no UV light, sunshine, mood, mood disorders or well-being) and language, 532 publications were excluded and 145 publications remained. After evaluating these 145 papers on abstract, another 126 were excluded for the following reasons: 9 were ideas, editorials or theoretical re- Finally, 7 studies were regarded eligible for this systematic review. All examined the effect of UV light or sunlight on mood, wellbeing or depressive disorders, applied directly to skin or eyes as an intervention in a group of healthy people, or patients diagnosed with a chronic disease. In 6 of these 7 studies, a control group was used for comparison, and one of the studies was observational.
| Study characteristics
Seven studies were assessed in this review, 5, 16, [20] [21] [22] [23] [24] ie 6 clinical trials of which 2 randomized controlled trials (RCTs), 2 cross-over studies, 1 prospective clinical trial, 1 study with a randomized parallel design, and 1 observational study. The characteristics of these studies are presented in Table 1 .
| Participants
Participants in the selected studies were healthy volunteers, 22 and patients with fibromyalgia syndrome, 20 dermatological conditions, 5 multiple sclerosis (MS), 21 and SAD. 16, 23, 24 The numbers of participants per study ranged from 13 23 to 198. 
| Methods of selected studies
All studies included a control group, except the observational study. 21 The control groups consisted of: (i) patients belonging to the same cohort but not receiving the intervention, 20, 22, 24 (ii) two control groups of which one of the same cohort having the intervention applied on a smaller surface of the body and one composed of healthy volunteers (receiving or not receiving the intervention), 5 or (iii) the study had a cross-over design. 16, 24 All studies used a repeated measure design for evaluation of the effect of the intervention.
| Interventions
The studies can be categorized into two groups according to the target site of the intervention: in one group the targeted organ was the skin, 5, [20] [21] [22] whereas in the other the intervention was applied to the eyes (with the retina as target). 16, 23, 24 The intervention used in the selected studies was UV light, 5, 20, 22 optical light combined with UV light ( 16, 23, 24 or outdoor exposure to sunlight. 21 In five of the studies, UV light was explicitly defined as UVA light (315-400 nm) 16, 20, [22] [23] [24] and in one study different groups were specifically receiving UVA, UVB (280-315 nm) or UVA+UVB light. 5 In the 4 studies in which skin was the target, UV light was applied either to the whole body, 5, 22 to smaller body areas, 5 or was not specified. 20 The duration of UV light exposure to the skin ranged from 3-6 weeks (2-3 times a week for 10-15 minutes). In the study with sun exposure, the duration of sun exposure was calculated in hours F I G U R E 1 PRISMA-based flowchart of the literature search, selection, and review process
TA B L E 1 Data extraction sheet and study characteristics
Study
Intervention
Site of action
Outcome measures
Results
MOOD Gambichler et al (2002)
RCT not blinded; N = 53; Volunteers Group 1: UVA whole body Group 2: No UVA Skin (2×/wk, 10-15 min)
1. BBS 2. FKB-20 T1 (baseline), T2 after first exposure, T3 end of study 1. UVA-exposed volunteers were more balanced (P = .01), less nervous (P = .03), more strengthened (P = .009) at T3 in comparison with T1 2. UVA-exposed volunteers showed more robustness and strength (P = .011) and more satisfaction with their own appearance (P = .04) at T3 in comparison with T1 Taylor 1. SIGH-SAD 2. BDI 1. The analysis of SIGH-SAD scores did not find significant effect of condition (P < .70), nor condition-by-time (P < .70).
2. Analysis of BDI didn't find significant effects of condition (P < .25), nor condition -by-time (P < .20). 
| Outcome measures
This systematic review focuses on the outcome measures mood, depressive disorders, and well-being.
| Mood
Mood was assessed in two studies. In the study with patients with fibromyalgia, mood was evaluated with the PANAS (Positive and Negative Affect Scale). 20 In the study with healthy volunteers, emotional state and physical awareness were assessed with the BBS (Basler Befindlichkeits-Scala) and the FKB-20 (Fragebogen zum Körperbild), respectively. 
| Well-being
Although well-being was frequently mentioned in two studies, 5, 20 none of these studies used a measurement scale specified for well-being.
| Risk of bias
The results of the risk of bias evaluation are summarized in Table 2 ; in some cases a narrative explanation is given for further clarification. the first study had little power because of the small number of participants and a possible order effect that can confound multiple cross-over designs; 23 20 , apart from not blinding the assessors, provided no information on mood changes in the second (randomized control) phase of their study. These authors focused on improvement of mood after each UV session in the acclimation phase when each participant underwent 6 tanning sessions at which they were exposed to two beds: a non-UV control bed and a UV treatment bed, which might simply be a consequence of an order effect, determined by the preference for a UV bed.
| Results of individual studies
Results of the individual studies are presented in Table 1 .
| Mood
Both studies using UV light targeted to skin and examining the psychological parameters showed a significant improvement in mood.
Gambichler et al 22 concluded that UVA-exposed volunteers were more balanced, less nervous, more strengthened and robust, and more satisfied with their own appearance after 3 weekly sessions of whole body UVA exposure.
Taylor et al 20 showed increased positive affect and decreased negative affect after UV stimuli in the acclimation phase of their study (6 sessions non-UV, followed by a UV bed) as measured by tanning preference, tanning expectations, increased well-being, relaxation, and decreased tension, stress and nervousness. The adjusted mean for the PANAS negative affect (10 low-50 high) after UV exposure in patients with fibromyalgia was 13.5 (SE .84) compared 
| Depression scores
Four of the 5 studies that investigated the effect of UV light reported a positive effect of UV radiation on depression scores in the examined populations. Both studies that applied UV exposure to the skin reported positive effects, 5, 21 two studies that applied UV exposure to the eye reported positive effects, 16, 23 and one study that applied UV exposure to the eye reported no positive effect on depression. 24 Edstrom et al 5 demonstrated a significant improvement in MADRS in both dermatological patients and volunteers after Three studies examined the effect of phototherapy enriched in UVA light exposed to the eye on depressive episodes of patients with SAD. Two of these three studies concluded that maximum efficiency of phototherapy on depression was observed in the groups receiving combined optical and UVA light. 16, 23 In the first study, the UVA light condition was the only treatment in which the traditional measures of depression and the HAM-D scores (P < .003) and BDI scores (P < .02) were significantly reduced 23 after 1-week treatment periods, one hour per day with different light spectrum and intensity.
In the second study in week 3 and 4 of the treatment, the maximum efficiency of 4-week treatment two hours per day was observed in the group with combined optical and UVA radiation which was significant only with respect to HDRS-SAD (P = .03 and P = .01, respectively), but not to the BDI score. 16 The third study found that addition of UV light to the optical spectrum in the phototherapy was not beneficial to alleviation symptoms of SAD during 2-week light treatment. 
| Area exposed to UV light
One of the studies proposed that UV light exposure of the whole body (rather than one part of the body) may be superior in influencing mood in a positive manner; 5 however, no other studies examined this aspect.
| Benefits of UV spectrum
In most of the studies, the fraction of UV light used was UVA light.
In the study of Edstrom, however, it was shown that UVB light was superior to UVA light in improving depressive symptoms. 5 
| D ISCUSS I ON
| Main findings
After an extensive search in multiple bibliographic databases, 145 papers were screened on title and abstract and 19 publications were assessed for eligibility. Of these publications, 7 met the inclusion criteria and are discussed in this systematic review.
The selected studies with skin as the target organ for UV light 5,20-22 were relatively heterogeneous. There was diversity in the population examined, in the psychological instruments used to assess mood and depressive disorders, and in the spectrum of the UV light that was applied. Although mood and depressive symptoms were analyzed in all these studies, they were not always the primary outcome. Other outcomes of UV light treatment were also investigated, eg effect on pain, fatigue, and dermatological conditions.
However, the effect of UV light on mood and depressive symptoms was consistently corrected for these other conditions.
The overall effect of UV light intervention on mood was positive in the two studies that examined this effect. 20, 22 However, the bias present in them made the results inconclusive.
None of the two studies using depression scales as a measurement for depressive symptoms conducted a separate analysis in a subgroup of depressed participants. 5, 21 The study population was a combination The trials targeting the retina with optical light enriched with the UV fraction were performed with a homogenous population of patients with SAD. 16, 23, 24 The UV light used in the studies was UVA light fraction added to the optical range. The studies had depression as their main outcome and the psychological instruments used to measure depression were comparable. Despite the homogenous populations and the comparable instruments used, the effects of UV light on SAD were variable. Duration and intensity of the light treatment in those studies was different and all of them had some degree of risk of bias.
| Strengths and limitations
For this review, an extensive search was made in major electronic databases and the references in key and selected articles were checked. All of the selected studies, apart from one that was observational, 21 used a control group, assessed mood and depressive disorders with more than one psychological instrument, and performed repeated measurements. The one observational study was of longer duration and had good statistical power. The effects in the observational study and the controlled studies (although relatively heterogeneous in character) concurred with each other.
Most RCTs had problems with allocation concealment and blinding. In the trials with UV light intervention affecting the skin, tanning can be a confounder and, if not blinded, can disturb the results. In one of the studies, the participants were blinded for the tanning and the lamps whereas the assessors were not. 20 In one of the studies, the number of participants was too low to have any statistical power. 23 In two of the studies, a per-protocol analysis was performed that could have influenced evaluation of the effect of the intervention; 5, 22 on the other hand, this may have provided a better picture of the effect of the treatment.
Finally, because of the small number of studies which met the inclusion criteria and the small amount of dispersion in the sample size, publication bias cannot be excluded.
| Comparison with other studies
Research on the beneficial effects of UV light on mood and depression is still in its infancy. 25 The effect of UV light on skin as a target [28] [29] [30] [31] [32] [33] In a recent meta-analysis, however, no evidence was found for a reductive effect of vitamin D supplementation on depression in adults. 34 Similarly, a recent prospective observational study of Knippenberg et al 21 , included in our review, reported that sun exposure, rather than 25(OH)D levels, was associated with fewer symptoms of depression and fatigue in patients with multiple sclerosis.
The relation between vitamin D, UVB and mood is still not well understood and possibly not all beneficial effects of UV radiation exposure occur through UVB induced vitamin D synthesis, 25 as we already discussed in the introduction.
| CON CLUS I ON S AND IMPLI C ATI ON S
Of the 7 included studies, 6 showed a positive effect of UV light on mood, depressive scores or SAD which supports a positive correlation between ultraviolet light exposure and mood improvement.
However, the small number of studies, their heterogeneity and the small number of participants in some studies, the existing bias, and the suboptimal study designs make it difficult to draw general conclusions about the effect of UV light on mood and depressive disorders.
Dating from ancient times, researchers have suggested that sunshine, apart from its deleterious effects, also has curative effects.
Because of the seasonal and meteorological changes, we cannot use sunshine in an unlimited way. This has triggered research to determine the components in sunshine that may have a beneficial effect on health, as well as their artificial reproduction. The administration of bright white visible light is considered to be the treatment of choice for patients with SAD. 35, 36 We have concentrated on the UV component of sunshine and its effect on mood and depressive disorders.
The results of the reviewed studies, the available knowledge on UV light mechanisms, and the neural, endocrine and immune regulation of mood provide sufficient information to warrant further research in this area. First of all, appropriate UV exposure schedules need to be established to predict and control DNA damage. 37 Second, a good design of future studies (double-blind, RCTs with sufficient power) is required. In addition, studies in the general population, as well as in cohorts of people with depressive disorders, are needed. Important aspects in this are a good definition and differentiation of the light spectrum, determination of the therapeutic range of the intervention, and the duration of the effect which can be ensured by repeated measurements.
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